BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s share price was down 0.9% during mid-day trading on Tuesday . The stock traded as low as $2.24 and last traded at $2.30. Approximately 80,597 shares were traded during trading, a decline of 100% from the average daily volume of 62,169,492 shares. The stock had previously closed at $2.32.
BioRestorative Therapies Trading Down 0.9 %
The stock has a market capitalization of $3.77 billion, a PE ratio of -2.15 and a beta of 102.36. The firm has a 50-day moving average price of $1.63 and a 200-day moving average price of $1.61.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Articles
- Five stocks we like better than BioRestorative Therapies
- 3 REITs to Buy and Hold for the Long Term
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What is the Hang Seng index?
- What Does the Future Hold for Eli Lilly?
- How to Calculate Options Profits
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
